Liver: An organ with predominant innate immunity

Blood circulating from the intestines to the liver is rich in bacterial products, environmental toxins, and food antigens. To effectively and quickly defend against potentially toxic agents without launching harmful immune responses, the liver relies on its strong innate immune system. This comprises enrichment of innate immune cells (such as macrophages, natural killer, natural killer T, and γδ T cells) and removal of waste molecules and immunologic elimination of microorganisms by liver endothelial cells and Kupffer cells. In addition, the liver also plays an important role in controlling systemic innate immunity through the biosynthesis of numerous soluble pathogen‐recognition receptors and complement components. Conclusion: The liver is an organ with predominant innate immunity, playing an important role not only in host defenses against invading microorganisms and tumor transformation but also in liver injury and repair. Recent evidence suggests that innate immunity is also involved in the pathogenesis of liver fibrosis, providing novel therapeutic targets to treat such a liver disorder. (HEPATOLOGY 2007.)

[1]  W. Jeong,et al.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity , 2006, Hepatology.

[2]  B. John,et al.  TLR-4 Regulates CD8+ T Cell Trapping in the Liver 1 , 2005, The Journal of Immunology.

[3]  Bin Gao,et al.  The complement system in liver diseases. , 2006, Cellular & molecular immunology.

[4]  R. Schwabe,et al.  Toll-like receptor signaling in the liver. , 2006, Gastroenterology.

[5]  G. Tiegs,et al.  Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. , 2005, Journal of immunology.

[6]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[7]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[8]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[9]  M. Kremer,et al.  Impaired liver regeneration and increased oval cell numbers following T cell–mediated hepatitis , 2007, Hepatology.

[10]  F. Braet,et al.  Hepatic Natural Killer Cells Exclusively Kill Splenic/blood Natural Killer-resistant Tumor Cells by the Perforin/granzyme Pathway , 2022 .

[11]  W. Born,et al.  The function of gammadelta T cells in innate immunity. , 2006, Current opinion in immunology.

[12]  J. Maher.  Interactions between Hepatic Stellate Cells and the Immune System , 2001, Seminars in liver disease.

[13]  P. Gasque,et al.  Extrahepatic complement biosynthesis: where, when and why? , 1997, Clinical and experimental immunology.

[14]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[15]  S. Friedman,et al.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of Hepatology.

[16]  D. A. Gomes,et al.  Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.

[17]  R. Sun,et al.  Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). , 2004, Gastroenterology.

[18]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[19]  Jörg Köhl,et al.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans , 2005, Nature Genetics.

[20]  A. E. Yeo,et al.  Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing , 2006, Hepatology.

[21]  M. Exley,et al.  To be or not to be NKT: Natural killer T cells in the liver , 2004, Hepatology.

[22]  H. Jaeschke.  Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[23]  T. Back,et al.  Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver. , 2006, Cancer research.

[24]  F. Chisari,et al.  Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo , 2005, Journal of Virology.

[25]  F. Leithäuser,et al.  The hepatic immune system. , 2002, Critical reviews in immunology.

[26]  P. de Knijff,et al.  Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. , 2005, Gastroenterology.

[27]  R. Sun,et al.  Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice , 2007, Hepatology.

[28]  N. Kaplowitz,et al.  Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. , 2004, Gastroenterology.

[29]  Takahiro Suzuki,et al.  Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.

[30]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[31]  K. Arihiro,et al.  Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans , 2006, Hepatology.

[32]  N. Van Rooijen,et al.  ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. , 2003, Gastroenterology.

[33]  B. Rehermann,et al.  The liver as an immunological organ , 2006, Hepatology.

[34]  G. Gores,et al.  Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis , 2003, Hepatology.

[35]  B. John,et al.  Cellular and molecular mechanisms of liver tolerance , 2006, Immunological reviews.

[36]  W. Born,et al.  The function of γδ T cells in innate immunity , 2006 .

[37]  D. Franchimont,et al.  Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver , 2006, Hepatology.

[38]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[39]  S. Friedman,et al.  Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference , 2007, Hepatology.

[40]  Z. Tian,et al.  Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response , 2005, Journal of viral hepatitis.

[41]  B. Rehermann,et al.  The liver as an immunological organ , 2004 .

[42]  S. Lemon,et al.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Iredale.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. , 2007, The Journal of clinical investigation.

[44]  D. Doherty,et al.  Innate and adaptive lymphoid cells in the human liver , 2000, Immunological reviews.

[45]  W. Jeong,et al.  Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis , 2007, Expert review of gastroenterology & hepatology.

[46]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[47]  G. McCaughan,et al.  Role of primary intrahepatic T‐cell activation in the ‘liver tolerance effect’ , 2002, Immunology and cell biology.

[48]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[49]  R. Sun,et al.  The roles of innate immune cells in liver injury and regeneration. , 2007, Cellular & molecular immunology.

[50]  A. Stavitsky,et al.  Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. , 2007, Gastroenterology.

[51]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[52]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.

[53]  N. Kaplowitz,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity , 2006, Hepatology.

[54]  A. Dolganiuc,et al.  Pattern recognition receptors: A contemporary view on liver diseases , 2006, Hepatology.

[55]  Yoshinobu Sato,et al.  Hepatic natural killer and natural killer T cells markedly decreased in two cases of drug‐induced fulminant hepatic failure rescued by living donor liver transplantation , 2005, Journal of Gastroenterology and Hepatology.

[56]  C. Laxton,et al.  Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection , 2007, Antimicrobial Agents and Chemotherapy.

[57]  A. Lentsch,et al.  Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. , 2002, The American journal of pathology.

[58]  F. Chisari,et al.  Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. , 2006, Proceedings of the National Academy of Sciences of the United States of America.